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Stsmmal'~] 
To elucidate mechanisms underlying neuroprotective properties of astrocytes in brain ischemia, 
production of neurotrophic mediators was studied in astrocytes exposed to hypoxia/reoxygenation 
(H/R). Rat astrocytes subjected to H/R released increased amounts of interleukin (IL) 6 in a 
time-dependent manner, whereas levels of tumor necrosis factor and IL-1 remained undetectable. 
IL-6 transcripts were induced in hypoxia and the early phase of reoxygenation, whereas synthesis 
and release of IL-6 antigen/activity occurred during reoxygenation. Elevated levels of 1I.-6 mRNA 
were due, at least in part, to increased transcription,  as shown by nuclear runoff analysis. The 
mechanism stimulating synthesis and release  of  IL-6 antigen by astrocytes was probably production 
of reactive oxygen intermediates  (ROIs), which occurred within 15-20 minutes after placing 
hypoxia cultures back into normoxia, as the inhibitor diphenyl iodonium inhibited the burst 
of ROIs and subsequent IL-6 generation (blockade of nitric oxide formation had no effect on 
ROI generation or IL-6 production). Enhanced IL-6 generation was also observed in human 
astrocytoma cultures  exposed to H/R.  Survival of differentiated PC12 cells exposed to H/R 
was potentiated by conditioned medium from H/R astrocytes, an effect blocked by neutralizing 
anti-IL-6 antibody. In a gerbil model of  brain ischemia, IL-6 activity was lower in the hippocampus, 
an area sensitive to ischemia, compared with IL-6 activity in the cortex, an area more resistant 
to ischemia. IL-6 antigen, demonstrated immunohistochemicaUy, was increased in astrocytes from 
ischemic regions of gerbil brain. These data suggest that H/R enhances transcription  of IL-6, 
resulting in increased translation  and release of IL-6 antigen after the burst of ROI generated 
early during reoxygenation. Release of IL-6 from astrocytes could exert a paracrine neurotrophic 
effect in brain ischemia. 
,•trocytes 
are the most abundant cell type in the central 
nervous system (CNS): and they have an important 
role in the maintenance of neuronal functions, including regu- 
lation of ionic/metabolic milieu (1), transport of neurotrans- 
mitters (2), as well as neurotrophic effects (3, 4). This varied 
spectrum of astrocyte functions confers survival advantage 
1 Abbreviations  used in  this paper: CNS,  central  nervous  system;  DPI, 
diphenyl  iodonium;  H/R,  hypoxia/reoxygenation;  LDH,  lactate 
dehydrogenase; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5,  diphenyl tetrazolium 
bromide; t-NMMA, N6-monomethyl r-arginine; NAC, N-acetyl cysteine; 
NGF, nerve growth factor; ROI, reactive oxygen intermediate; RT-PCR, 
reverse transcriptase  PCR; SOD, superoxide dismutase. 
of neurons cocultured with astrocytes (3) and enables astro- 
cytes to activate immune mechanisms (5-7).  The potential 
of astrocytes to contribute to the host response in ischemia 
is suggested by their proliferation at sites subjected to isch- 
emia/reperfusion and by their capacity to phagocytose cel- 
lular debris (8, 9). 
Cultured mononuclear phagocytes  have been shown to 
produce  mediators  on exposure to  hypoxia/reoxygenation 
(H/R) that are likely to contribute to the pathogenesis  of 
the tissue response in ischemia/reperfusion (10). In this con- 
text, Colletti et al. (11) showed that hepatic lobar ischemia 
induced release of  TNF, which increased pulmonary vascular 
permeability.  IL-6, apparently derived from ischemia lym- 
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cellular adhesion molecule 1 in cardiac myocytes (12). In the 
brain, astrocytes, as well as microglia and infiltrating macro- 
phages, have the capacity to synthesize cytokines, which alter 
the properties  of myriad target cells  (13). This led us  to 
hypothesize that cytokine(s) released by astrocytes  exposed 
to H/K  might exert  a neuroprotective effect in the setting 
of ischemia. 
The results of our study indicate that exposure of cultured 
rat astrocytes  to hypoxia induces IL-6 transcription, which 
continues in the early phase of reoxygenation, and that sub- 
sequent reoxygenation results in a burst of oxygen free rad- 
ical production stimulating translation and release of bioac- 
tive IL-6 from the cell.  Enhanced production of IL-6 was 
observed  in a cultured human astrocyte line and in a gerbil 
model of bilateral  brain ischemia.  IL-6 derived from H/R 
astrocytes  promoted  the  survival  of differentiated  PC12 
pheochromocytes exposed to H/R.  Taken  together,  these 
studies indicate that the astrocyte response  to H/R sets in 
motion events that could contribute to minimization and re- 
pair of ischemic lesions. 
Materials and Methods 
Cell Culture.  Astrocytes  and microglial  cells were obtained from 
neonatal rats by a modification of a previously described method 
(14, 15). In brief, cerebral hemispheres were harvested from neo- 
natal Sprague-Dawley  rats within 48 h of  birth, carefully separated 
from meninges, and digested at 37~  with Dispase II (3 mg/ml; 
Boehringer-Mannheim, Mannheim, Germany) in MEM with  Jok- 
lick's modification (GIBCO BILL,  Gaithersburg, MD). Cells were 
collected  by centrifugation O00g for 10 min), resuspended  in MEM 
supplemented with FCS (10%; Filtron, Technology  Corp., North- 
borough,  MA),  and plated in  175-cm  ~ culture flasks (approxi- 
mately two brains/flask). After 10-14 d, cells were incubated for 
48 h with cytosine arabinofuranoside  (10 gg/ml; Wako Chemicals, 
Osaka, Japan) to prevent growth offibroblasts and oligodendroglial 
cells. After agitating culture flasks  on a shaking platform (Bioshaker 
BR-30L; Tautek, Tokyo,  Japan) for 3 h at 37~  adherent cells  were 
collected and characterized as astrocytes  (see below). Cells floating 
in the medium were then distributed in 24-well plates, incubated 
for 30 min at 37~  and washed vigorously with HBSS. The cells 
adherent  after  this  wash were harvested and  characterized as 
microglia  cells. Their  identification was  confirmed  immuno- 
histochemically  by use of monoclonal antibodies for glial fibrally 
acidic protein and MAC-1 (generously  provided  by Dr. A. Wanaka, 
Second Department of  Anatomy,  Osaka University  Medical  School), 
respectively. Cultures with an homogeneous  cell population (>98% 
staining for one of these two markers) were used for experiments. 
U373 cells, a human astrocyte cell line, were generously provided 
by Dr. T. Hirano (Osaka University Medical School). Cells used 
in the cytokine  activity  assays-A375S2 cells (IL-1), bM cells (TNF), 
and MH-60 cells (IL-6)-were generously  provided  by Otsuka Phar- 
maceutical Company (Tokyo,  Japan), Dainippon Pharmaceutical 
Company (Osaka, Japan), and Dr. T. Hirano, respectively. 
Conditions  for ExFosure of  Cell Cultures to H/R.  Cells  were plated 
in either 24 or 6-well plates or 75-cm  2 or 150-cm  2 dishes (Coming, 
Vernon, NY) and exposed to H/R as described (16, 24). At the 
indicated time points, pH and oxygen partial pressure in the cul- 
ture medium were monitored by use of a blood gas analyzer (ABb 
2;  Radiometer, Copenhagen, Denmark).  Viability of astrocytes 
during the experiments was assessed by several criteria, including 
general morphologic characteristics, phase contrast microscopy, 
trypan blue exclusion, and release of lactate dehydrogenase  (LDH) 
into culture supematants (the latter determined with a kit obtained 
from Sigma  Chemical  Co., St. Louis,  MO). In addition,  maintenance 
of general cellular  biosynthetic and energetic metabolism  was evalu- 
ated by incorporation of [3H]leucine into TCA-precipitable mate- 
rial, as described (17), and measurement of cellular ATP levels by 
chromatography of cell lysates  on reversed-phase HPLC (18). Cel- 
lular protein content was assessed by the method of Lowry et al. 
(19). In some experiments, the entire protocol was performed in 
the hypoxia chamber, whereas in other instances, cultures were ex- 
posed to ambient air for varying times after hypoxia (i.e., H/R). 
Cytokine Activity Assays.  Activities  of Ibl, TNF, and Ib6 in 
medium conditioned by astrocytes  during exposure to hypoxia or 
H/R were studied by use of the II.,1-sensitive  A375S2 cell growth 
inhibition assay  (20), the TNF-sensitive  DM cell  viability  assay  (21), 
and the II~6-dependent MH-60 cell proliferation  assay  (22), respec- 
tively. In each assay, cell proliferation/viability was assessed  by use 
ofMTT (3-[4,5-dimethylthiazol-2-yl]-2,5,  diphenyl  tetrazolium  bro- 
mide), as described (23). The MTT assay  was performed by plating 
either A375S2 cells, L-M cells, or MH-60 cells in 96-well plates 
(ml0  s cells/well), incubating them for the indicated  period, adding 
astrocyte- (or microglia-) conditioned medium for 24 h, and then 
MTT. 6 h later, cells were lysed  in HC1 (0.04 N)/isobutanol (96%, 
vol/vol), and reduction of MTT was measured by absorbance at 
570 nm by use of an ELISA reader (UV-160; Shimadzu, Kyoto, 
Japan). Bioactivity of each cytokine was determined by compar- 
ison with a standard curve generated with A375S2 cells, MH-60 
cells, or DM cells and known concentrations  of  recombinant  human 
IL-1 (generous gift from Otsuka Pharmaceutical  Co.), Ib6 (gener- 
ously provided by Dr. T. Hirano) or TNF (Dainippon Pharmaceu- 
tical Company). In certain assays, neutralizing anti-murine Iblcr 
antibody (10 #g/ml; Genzyme Corp., Cambridge, MA) or anti- 
routine TNFa antibody (10 gg/ml; Genzyme Corp.) was added 
to astrocytes  4 h before  reoxygenation. In other experiments, either 
diphenyl iodonium (DPI), N-acetyl cysteine (NAC), N6-mono  - 
methyl t-arginine (t-NMMA), or aliopurinol  (all from Sigma  Chem- 
ical Co.) was added to cultures 10 rain before reoxygenation or 
at the indicated time points. In some experiments, hypoxic astro- 
cyte-culture  medium  was  replaced with  arginine-free MEM 
(GIBCO BKL) 4 h before reoxygenation. 
ImmunopreciFitation of Metabolically Labeled 11.-6 Antigen.  Rat 
astrocytes (--107 cells) were incubated in methionine/cysteine-poor 
MEM (GIBCO BRL) under normoxic or hypoxic conditions for 
24 h, and the [3SS]methionine  (0.2 mCi/rul; 1,134 Ci/mmol; New 
England Nuclear, Boston, MA) and [3SS]cysteine (0.1 mCi/ml; 
1,038 Ci/mmol; New England Nuclear) were added; labeling con- 
tinued for another 8 h under each condition. For reoxygenated 
samples, metabolic labeling was started 29 h after the onset ofhyp- 
oxia and was continued in the presence of [3SS]methionine/cysteine 
for another 3 h under hypoxia and up to 5 h after reoxygenation 
(total labeling time was 8 h in each case). Where indicated, cyclo- 
heximide (10 gg/ml; Sigma Chemical Co.) or DPI (50 #M; Sigma 
Chemical Co.), a neutrophil-type NADPH oxidase  inhibitor (25), 
was added at the beginning of  reoxygenation and remained present 
until the end of the experiment. The positive control for induction 
of IL6 antigen was obtained from the supernatant of astrocytes 
treated with LPS (10 ng/ml; Sigma Chemical Co.) for 4 h. Super- 
natants of astrocytes radiolabeled under each condition were sub- 
jected to immunoprecipitation with rabbit anti-murine I1.-6 IgG 
(20 gg/ml; R&D Systems, Inc., Minneapolis, MN) by addition 
of antibody to conditioned medium (15  ml derived from ~107 
2298  Ib6 and Astrocytes cells) and incubation for 12 h at 4~  Then, a suspension of Staphy- 
lococcus protein A (0.4 ml/tube; 10%; IgGSorb, Enzyme Center, 
Malden, MA) was added. The mixture was incubated for 30 rain 
at 4~  and the precipitate was collected by centrifugation (5,000 
rpm for 10 min). The pellet was washed three times in Tris (20 
raM; pH 7.4)-buffered  saline (0.1 M) containing Triton X-100 
(0.05%) and EDTA (1 mM). Samples were then boiled in reducing 
sample buffer (26) and applied to SDS-PAGE (12.5%).  Gels were 
fixed and soaked in EN3HANCE (New England Nuclear), dried, 
and then autoradiography was performed. Immunoprecipitation 
of Ib6 from metabolically labeled cell lysates was performed ac- 
cording to the same method as described above, except that cell 
pellets were washed three times with Tris (20 raM; pH 7.4)-buffered 
saline (0.1 M), frozen at  -80~  thawed, and lysed in the same 
buffer, also containing EDTA (5 raM), PMSF (1 mM), and trasylol 
(100 U/nil). In some experiments, supernatant and cell lysates from 
reoxygenated astrocytes  were preincubated with routine recombinant 
IL-6 (1 gg) for 2 h before the addition of anti-Ib6 antibody. Re- 
verse transcriptase  (KT) PCR was performed to assess Ib6 tran- 
scripts and Southern blot hybridization. 
Rat astrocyte  total RNA (derived from ~2  x  107 cells) was 
extracted by use of the acid guanidium-thiocyanate  phenol chloro- 
form method (27) at the indicated  time points, and eDNA was 
prepared by incubating 5 gg RNA for 1 h with RT (BILL, Kyoto, 
Japan) and oligo dT primer. PCtL was performed by use of 24 cycles 
(94~  for 30 s, 64~  for 40 s, and 72~  for 90 s) and the following 
primers derived from the rat Ih-6 sequence (28): 5' GAC TGA TGT 
TGT TGA CAG CCA CTG C 3' (sense) and 5' TAG CCA CTC 
CTT CTG TGA CTC TAA CT 3' (antisense). The reaction mix- 
ture consisted  of primers  (0.2/~M), RT product (1/~g), dNTP 
(25 gM), and ct-[32p]dCTP (0.1 gM). Products were subjected to 
agarose gel (1%) electrophoresis and autoradiography using x-ray 
film (Fuji Film, Tokyo, Japan). The amount of IL-6 transcript was 
semiquantitatively assessed by comparison with the PCR product 
of actin transcript amplified simultaneously as an internal control 
(10). PCIL products with IL-6 primers amplified by the same pro- 
cedure described above without ct-[~ZP]dCTP were identified by 
digestion with Hinfl (28) and Southern blot hybridization using 
radiolabeled murine Ib6 eDNA probe (generously provided by Dr. 
T. Hirano) according  to the method described previously  (29). 
Nuclear Run-off Analysis for IL6.  To evaluate lb6 transcription, 
nuclear run-off assay analysis was performed by use of previously 
described methods (30). In brief, nuclear suspension (0.2 ml), ob- 
tained from ,~2  x  107 astrocytes at the indicated time points, was 
incubated with CTP, ATE and GTP (0.5 ram each) in the pres- 
ence c~-[32p]UTP (250/~Ci, 3,000 Ci/mmol; New England Nu- 
clear). The positive controls for induction of Ib6 transcription were 
nuclei isolated from astrocytes treated with LPS (10 ng/ml; Sigma 
Chemical Co.) for 4 h. Samples were subjected to phenol/chloro- 
form extraction, and RNA was precipitated  and resuspended  in 
hybridization buffer. Hybridization to denatured murine Ib6 (20 
/~g) and human ~-actin (5/~g; control) dot blotted onto nylon mem- 
branes was performed at 42~  for 2 d. Filters were then washed, 
dried, and exposed to x-ray film. 
Assays for Reactive Oxygen Intermediates (ROIs) and NADPH Ox. 
idase Activity.  ROIs were measured by lucigenin-based  chemilu- 
minescence by adding bis N-methyl acridinium nitrate (lucigenin; 
0.2 mg/ml; Sigma Chemical Co.)/CaC12 (10 raM) to hypoxic as- 
trocytes (~107 ceils) suspended in PBS at the time of reoxygena- 
tion. Chemiluminescence was detected by use of a luminescence 
reader (BR.b301; Aloka, Tokyo, Japan)  after equilibration  of the 
cell suspension  with 5%  CO2/room air (31). NADPH activity 
was measured  as described  (32) by incubating astrocytes  (,-107 
ceils)  for  3  h  at  37~  in  2  ml  PBS, CaC12 (5  mM),  and 
cytochrome C (5 gg/ml). Where indicated,  DPI (50/~M), an in- 
hibitor of NADPH oxidase, was added to the incubation mixture. 
After the incubation period,  cell suspensions  were centrifuged 
(1,000 g for 5 min), and ODs~,m in the supernatant was measured 
with a spectrophotometer (UV-160; Shimadzu, Kyoto,  Japan). Su- 
peroxide production was determined based on the difference of ad- 
sorbance at 540 nm in the absence and presence of superoxide dis- 
mutase (SOD; 1 gg/ml; Sigma Chemical Co.). NADPH oxidase 
activity was calculated based on the difference of superoxide produc- 
tion in the absence and presence of DPI. 
Effect of ROIs on the Production of 11.6.  Rat astrocyte cultures 
plated on 24-well plates were incubated with hydrogen peroxide 
(0-12 raM, Wako Chemicals) under either hypoxic or normoxie 
conditions for 1 rain, washed three times with MEM containing 
FCS (0.1%) preequilibrated with each atmospheric condition, and 
further incubated for the indicated period under that condition. 
II~6 activity daborated into the conditioned medium was measured 
by use of the MH-60 proliferation  assay. 
Effect of Astwcyte-conditioned Medium  on  the Survival  of PC12 
Cells.  Rat astrocytes were plated on 150-cm  2 dishes, exposed to 
hypoxia (32 h), and reoxygenated in serum-free MEM. Astrocyte- 
conditioned medium ('~40 ml) was collected 16 h after reoxygena- 
tion and concentrated ~20-fold by ultrafiltration (Amicon, Beverly, 
MA). PC12 ceils (generously provided by Dr. A. Wanaka) were 
plated in 24-well plates (~5  x  104 cells/wen)  and differentiated 
as previously described (33). Differentiated PC12 cells were exposed 
to hypoxia (24 h) in MEM containing FCS (0.1%) and Hepes (7 
raM; pH 7.4). At the onset of reoxygenation, medium was replaced 
with either MEM containing FCS (0.1%),  murine recombinant 
IL-6 (10 ng/ml; Genzyme) or concentrated astrocyte-conditioned 
medium exposed to H/P., and supplemented with FCS (0.1%). In 
some  experiments,  concentrated astrocyte-derived  medium was 
preincubated with either neutralizing antimutine IL-6 antibody (10 
#g/ml; K&D Systems) or neutralizing antimurine nerve growth 
factor (NGF)  antibody (10 gg/ml;  generous  gift from Dr.  A. 
Wanaka) for 60 min at 37~  The viability of differentiated PC12 
cells was assessed by morphologic criteria and trypan blue dye ex- 
clusion  24 h after reoxygenation. 
Assays of lL6 Activity from Brain Extract and Immunohistochem- 
istry.  Adult Mongolian gerbils anesthetized  by ether inhalation 
were subjected to transient forebrain ischemia by bilateral clipping 
of common carotid arteries for 5 min by the method described pre- 
viously (34). In sham-operated  animals, carotid arteries were ex- 
posed without any further manipulations.  At the indicated times, 
gerbils were killed by decapitation and the brain was separated on 
a cooled plate (4~  under sterile conditions. The cerebral cortex 
and the hippocampus  were quickly frozen in liquid nitrogen and 
kept at - 70~  Brain tissues were then homogenized with a poly- 
tron in 2 ml (cortex) or 0.5 ml (hippocampus)  of PBS (pH 7.4). 
After  centrifugation  at  10,000  g  for  10  min  at  4~  tissue 
homogenates were filtered twice through 0.22-/zm cellulose falters 
(Sumilon,  Osaka, Japan)  and subjected to the IL-6 activity assay, 
as described above. Protein content was determined by use of a 
microprotein assay kit (BioRad Laboratories, Richmond, CA). At 
each time point, blood samples were collected from the tail vein 
of animals, plasma was separated by centrifugation (1,000 g for 5 
min), and cytokine activity was assessed as above. 
For immunohistology, gerbil brain was fixed in paraformalde- 
hyde (4%) and embedded in parat~n.  Sections were reacted with 
goat anti-mouse I1.-6 (20 gg/ml; K&D Systems) or nonimmune 
goat IgG (20 #g/ml; Sigma Chemical Co.). Sites of binding of 
primary antibody were visualized with rabbit  anti-goat peroxi- 
2299  Maeda  et al. dase-conjugated  affinity-purified  IgG (1 #g/ml). Where indicated, 
after sections were reacted with anti-mouse Ib6 and the peroxi- 
dase conjugate, sections were decolorized, antibodies were eluted 
with ethanol (100%), and peroxidase was blocked by hydrogen 
peroxide  (0.5% for 30 rain). Then, sections  were  reacted  with rabbit 
anti-glial fibrillary acidic  protein IgG (75/~g/ml; Sigma Chemical 
Co.), and sites of antibody binding were visualized with goat 
anti-rabbit IgG conjugated to alkaline phosphatase (0.5/~g/ml; 
Sigma Chemical Co.). 
Statistical analysis was performed by Neuman-Kuehl's  methods 
for multiple comparison after analysis of variance. 
Results 
Astrocyte Viability  During Exposure to H/R.  Oxygen ten- 
sion in the medium fell to "~8 tort within 3-5 h after transfer 
of astrocyte cultures to the hypoxia chamber.  Cell viability 
was well maintained throughout H/R,  based  on multiple 
criteria  including release of LDH into the culture superna- 
tant, trypan blue exclusion, and morphologic features. Total 
cellular protein synthesis in cultures exposed to hypoxia for 
48 h, assessed by incorporation of [3H]leucine, decreased to 
68.4  •  1.8% after 48 h, compared with normoxic control 
cultures, and was paralleled by a decrease in cellular ATP con- 
tent (70.2  •  2.8% ofnormoxic culture). During the period 
of reoxygenation, protein synthesis  appeared  to rebound, 
achieving levels ~1.7 times that seen in normoxia within 3 h. 
General protein synthesis and ATP returned to pretreatment 
(i.e., normoxic) levels within 24 h of replacement into the 
ambient atmosphere. Cellular protein content was not sig- 
nificantly diminished under these conditions compared with 
cultures maintained in normoxia. 
Induction of Cytokines  from Cultured  Astrocytes  by H/R.  Con- 
ditioned medium from astrocytes exposed to H/R promoted 
the proliferation of MH-60 cells, suggesting that increased 
amounts of IL-6 activity were present (Fig. 1, A and B). Con- 
sistent with this concept, neutralizing anti-routine IL-6 an- 
tibody blocked the enhanced proliferation of MH-60 cells 
resulting from H/R astrocyte-conditioned medium (Fig.  1 
B). Release oflL-6 by astrocytes required a period of hypoxia 
(-->16 h) followed by reexposure to normoxia (i.e., reoxygen- 
ation); IL-6 activity was only found in culture supernatants 
during the subsequent reoxygenation period, being detect- 
able within 8 h  and increasing up to 32 h (Fig.  1 A).  No 
IL-6 activity was detectable  in the conditioned medium or 
cell lysates of astrocytes exposed only to hypoxia or normoxia. 
The degree of hypoxia was also critical,  as only severe ox- 
ygen depletion (p02 '~8-24  tort)  induced astrocyte IL-6 
production (Fig.  1 B). The specificity of H/R for induction 
of astroeyte IL-6 was suggested by the observation that cul- 
tured microglia subjected to the same conditions did not pro- 
duce IL-6, although exposure of microglia to LPS did result 
in release of IL-6 activity (Fig.  1 C). In contrast to H/R- 
Figure  1.  Elaboration of IL-6 activity by cul- 
tured astrocytes and microglia exposed to H/R. 
(A) Rat astrocytes or microglia (~105 cells/well) 
were exposed to hypoxia for the indicated periods 
(0-32 h) and then reoxygenated as described in 
Materials  and Methods. Then, culture supernatants 
were harvested and IL-6 activity in the medium 
(500/~l/well) was measured with the MH-60 cell 
proliferation assay. (B) Astrocytes were exposed to 
the indicated oxygen tensions for 32 h and then 
reoxygenated (i.e., returned to normoxia). Condi- 
tioned medium was harvested at the end of byp- 
oxia  (H~oxia)  and  16  h  after  reoxygenation 
(Reoxy), and IL-6 activity was assessed with the 
MH-60 proliferation  assay. Samples from  reox- 
ygenated astrocytes were preincubated with neu- 
tralizing antimurine  II.-6 antibody (10 #g/ml) for 
30 rain before MH-60 assay  (indicated by ol-IL.6). 
(C) Microglial cultures were exposed to hypoxia 
(12 or 32 h),  and samples were harvested at the 
end of hypoxia (0) and 4, 8, and 24 h after reoxy- 
genation. Microglia were also activated  by exposure 
to LPS (20 or 200 ng/ml). In each case, n  =  8, 
and values are expressed as the mean _+  SD. 
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Figure 2.  Effect  of H/P, on astrocyte production of TNF and II:1, and the effect of anti-TNF and anti-IL-1 antibody on astrocyte release of IL-6 
in response to H/R.. (A and B) Cultured rat astrocytes (,~10  s cells/well) were exposed to hypoxia for either  12 or 32 h followed by reoxygenation. 
At each time point (0, 4, 8, and 24 h after reoxygenation),  TNF (A) and II.-1 (B) activity in the conditioned medium was measured by use of the 
bM cell cytotoxicity assay and the A375S2 cell growth inhibition  assay, respectively. Activity of cytokines present at the end of the period of hypoxia 
was expressed as time point O. Positive controls included astrocytes exposed to the indicated concentration of LPS for 32 h. (C) Either blocking antimu- 
fine TNF IgG (10 #g/ml) or antimurine  II.-1  IgG (10 #g/ml) was added to culture medium of normoxic astrocytes (Normo)  or 4 h before reoxygenation 
(Reox; these cultures had already been subjected to hypoxia for 32 h), and after 12 h of incubation, release of II.-6 activity was measured by use of 
the MH-60 assay. In each case, n  =  8, and values are expressed as the mean _+  SD. 
induced astrocyte production of IL-6, no TNF or IL-1 ac- 
tivity was detected even after prolonged exposure to hypoxia 
or H/R (Fig.  2, A  and B), but astrocytes exposed to LPS 
(positive controls) produced both IL-1 and TNF (Fig. 2, A 
and B). Neither neutralizing antibody to murine TNF nor 
IL-1 altered production of IL-6 by astrocytes exposed to H/P, 
(Fig. 2 C). These data indicate that H/R-induced astrocyte 
production of IL-6 is not likely to result from prior endoge- 
nous production of TNF or IL-1. 
PCP, analysis using IL-6 primers indicated that IL-6 mRNA 
was induced in astrocytes  during hypoxia (Fig.  3 A), even 
though there was no evidence of increased IL-6 activity until 
the subsequent reoxygenation period. Levels  of IL-6 transcripts 
increased at the end of hypoxia compared with normoxia (Fig. 
3 A), whereas amplification of/3-actin mRNA showed no 
significant change in transcript levels (Fig. 3 C). During re- 
oxygenation, there was a further increase in the level of IL-6 
transcripts for up to  1 h, thereafter falling off to the nor- 
moxic baseline by 8 h (Fig. 3 A). Identity of amplicons with 
IL-6 primers as derived from IL-6 mRNA was confirmed 
by probing blots with radiolabeled IL-6 cDNA and cleavage 
of PCR products by HinfI (Fig. 3 B) (28). Elevation of steady- 
state IL-6 message levels during hypoxia and early in reoxy- 
genation was associated  with increased transcription as demon- 
strated  by the nuclear  run-off assay (Fig.  4). 
Taken together, these data suggest that release of IL-6 oc- 
curred from H/R-astrocytes during reoxygenation, whereas 
the levels  of IL-6 mRNA began to increase substantially during 
hypoxia.  To gain further insights into mechanisms under- 
lying the synthesis of IL-6 antigen, immunoprecipitation of 
metabolically labeled astrocyte cultures exposed to hypoxia 
or H/R was performed. Immunoprecipitation of superna- 
tants from astrocytes  exposed to hypoxia alone showed no 
evidence of an immunoreactive IL-6 band, as was also ob- 
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Figure 3.  PCR. analysis of IL-6 transcripts, identification of amplified 
IL-6 transcripts, and internal  control. RNA extracted from cultured astro- 
cytes (~,,2 x  107 cells) exposed to H/R (0, 8, 16, or 32 h under hypoxia 
and 1, 3, 8, or 16 h after reoxygenation) was processed as described and 
amplified by use of either rat Ib-6 primers (A) or rat B-actin primers (con- 
trol; C). In B, the identity of PCR-amplified ID6 transcripts after 32 h 
of hypoxia (lane 2) was confirmed by either  Southern blotting (lane 1) 
using murine 32p-labeled  1I.-6 cDNA or by cleavage of the IL-6 amplicon 
with the restriction  enzyme HinfI (lane 3). Figure 4.  Nuclear run-off analysis of II.-6 transcripts in astrocytes ex- 
posed to hypoxia and H/R. Astrocytes (2  x  10Y cells) were exposed to 
either LPS (10 ng/ml for 4 h) or H/R.  (0,  16, or 32 h of hypoxia [/4] 
and 0.5 or 6 h of subsequent reoxygenation),  and nuclei were extracted 
with Tris-buffered saline containing  NP-40 (1%). Nuclear run-off  analysis 
was performed as described, then hybridized with murine Ib6 and ~-actin 
(control) eDNA probes, and subjected to autoradiography. 
production/release of material immunoprecipitated by anti- 
IL-6 antibody (Fig. 5 A, R-Cx), indicating a mechanism in- 
volving de novo protein synthesis. 
Generation of ROIs by Astrocytes Exposed to H/R and their 
Role in IL-6 Production.  Since expression of IL-6 antigen oc- 
curred only after reoxygenation of hypoxic astrocytes, we con- 
sidered the hypothesis that ROIs are important in triggering 
synthesis of IL-6 antigen. First,  the time course for genera- 
tion of ROIs by astrocytes exposed to H/R. was studied by 
lucigenin-dependent  chemiluminescence: a peak of ROIs was 
evident within 15 min of replacement of cultures from hyp- 
oxia back to normoxia, lasting for •60  min (Fig. 6 A). Ad- 
dition of NAC to the medium suppressed ROI generation 
served with cultures exposed to normoxia (Fig.  5 A, Hypo 
and Normo). Consistent with these data, immunoprecipitates 
of cell lysates from hypoxia astrocytes gave no immunoreac- 
tive band with anti-IL-6 antibody (see below), although mul- 
tiple background bands were observed (Fig. 5 B, H~o and 
Normo). In contrast, immunoprecipitation of supernatants 
from astrocytes exposed to H/R yielded an ,x,26-kD  band 
whose appearance  was blocked by addition of excess unla- 
beled IL-6 during incubation of astrocyte-derived samples with 
the primary antibody (Fig.  5 A, Reox and R-Cold, respec- 
tively).  Similarly, precipitation of metabolically labeled as- 
trocyte lysates gave an ~,,26-kD band (as in the conditioned 
medium) whose appearance was also blocked by excess unla- 
beled IL-6 (Fig. 5 B, Reox and R-Cold, respectively).  Inclu- 
sion of cycloheximide in the medium prevented astrocyte 
Figure 5.  Immunoprecipitation  of IL-6 from (A) metabolically labeled 
astrocyte culture supernatant  and (B) cell lysate. Astrocytes ("~107) were 
maintained in cysteine/methionine-poor  medium and were labeled after 
either hypoxia (Hypo) alone, hypoxia followed by renxygenation (Reox), 
or exposure to normoxia (Norrao)  alone by adding to [3sS]methionine  and 
[3sS]cysteine for the final 8 h of the experiment  (details of the protocol 
are described in Materials and Methods).  As a positive control, superna- 
tant was obtained from astrocytes incubated with LPS (10 #g/ml) for 4 h. 
At the time of reoxygenation, either cycloheximide (10 #g/ml; R-Cx) or 
DPI (50 #M; R-DP/) was added to the medium as indicated.  In some 
experiments, unlabeled murine recombinant  IL-6 (1 #g) was preincubated 
2 h before addition  of anti-Ib6 IgG to reoxygenated cultures  (R-cold). 
Immunoprecipitates were solubilized in SDS-PAGE  sample buffer and sub- 
jected to SDS-PAGE (12.5%). Migration of molecular weight standards 
run simultaneously is shown in kilodaltons. Details of procedures are de- 
scribed in Materials and Methods. 
Figure 6.  Generation of ROIs by cultured astrocytes exposed to H/R: 
effect of arginine-free medium (AF), L-NMMA (LNA),  DPI, NAC, al- 
lopurinol (AL), and SOD. (A) Astrocytes ("~10~) were exposed to hyp- 
oxia for 32 h, and cells  were resuspended  in PBS containing CaCI2 (5 mM) 
and lucigenin (0.2 mg/ml). Either DPI (50/~M) or NAC (20 mM) was 
added at the time of reoxygenation,  and chemiluminescence was moni- 
tored at the noted time intervals. (B) The experiment was performed as 
in A except that cells were exposed to hypoxia for 32 h and reoxygenation 
for 60 min after the addition of the indicated concentration  of allopurinol 
(AL; 10/~M), L-NMMA (LNA), NAC, or DPI. AF indicates experiments 
in which cultures were preincubated with arginine-free medium 4 h be- 
fore and during reoxygenation.  * *p <0.01 by Nenman-Keuhl's analysis. 
(C) Superoxide generation by astrocytes ('~107 cells) during the first 3 h 
of reoxygenation after 32 h of hypoxia was measured with the cytochrome 
C reduction assay  by determining the difference in OD at 540 nm in the 
absence minus the presence of SOD (1 #g/ml; R3). Suppression of su- 
peroxide generation on addition of DPI (50/~M) to astrocytes subjected 
to H/K as above is shown by the bar denoted by +DPI. Superoxide gener- 
ation by astrocytes exposed to hypoxia (32 h) or nomoxia (N) alone is 
also shown. For these experiments, n =  6, and the mean _+ SD is shown. 
Details of procedure are described in Materials and Methods. 
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6, A and B). In contrast,  allopurinol (Fig. 6 B, AL) was not 
an effective inhibitor of ROI formation by H/K astrocytes, 
consistent with lack of  involvement ofxanthine oxidase. Since 
DPI also inhibits nitric oxide synthetase [(35); the latter en- 
zyme  can be induced in cultured astrocytes (36)], it was neces- 
sary to assess the contribution of nitric oxide to induction 
of IL-6. Preincubation  astrocyte cultures with arginine-free 
medium or t-NMMA had no effect on the subsequent gener- 
ation of KOIs (Fig. 6 B, AF and LNA). These data suggest 
that NADPH oxidase-like activity in astrocytes likely ac- 
counted for generation of gOIs.  The nature of the ROIs 
generated by H/R astrocytes was further characterized in 
the presence of SOD by use of the cytochrome C reduction 
assay (Fig. 6 C). Superoxide generation, the component of 
cytochrome C reduction suppressed in the presence of SOD 
(Fig. 6 C, R3) was blocked by inclusion of DPI (Fig. 6 C, 
R3,  +DP/), whereas astrocytes exposed to hypoxia or nor- 
moxia alone (Fig. 6 C, H32, N) demonstrated no ROI for- 
mation. These data suggest that superoxide formation in as- 
trocytes subjected to H/R was due to an NADPH oxidase-like 
activity. 
To determine if there was a link between generation of 
ROIs by astrocytes exposed to H/R and production of IL-6 
antigen, the effect of DPI on IL-6 expression was examined. 
When H/R-astrocytes were subjected to immunoprecipita- 
tion in the presence of  DPI, suppression of  the IL-6-immuno- 
reactive band was observed in both supernatants and cell ly- 
sates (Fig. 5, A and B, R-DP1). A similar inhibition of IL-6 
release  by astrocytes exposed to H/R was observed when IL-6 
activity was studied in conditioned medium in the presence 
of DPI (Fig. 7 A) (DPI had no effect on determination of 
IL-6 activity in the bioassay when tested in the presence of 
exogenous IL-6). In addition, inclusion of I.-NMMA had no 
effect on subsequent generation of IL-6 (Fig. 7 A, LNA). 
Thus, generation of  ROIs, which occurs relatively  early during 
the period of reoxygenation,  has an important stimulatory 
effect on the synthesis of IL-6 antigen. Consistent  with this 
concept, to inhibit IL-6 release, DPI had to be added either 
before or very close to the beginning of reoxygenation,  as 
30 min later it was ineffective in preventing  IL-6 release/ 
production (Fig.  7 B). 
flour hypothesis concerning ROIs as the stimulus for trans- 
lation and release of IL-6 is correct,  we reasoned that hyp- 
oxic astrocytes,  with increased  levels  of IL-6 transcripts, should 
be capable of  producing increased amounts of IL-6 if exposed 
to an exogenous source of  ROIs, even in continued hypoxia. 
To test this, astrocytes preincubated under hypoxia were ex- 
posed to hydrogen peroxide for 1 rain (cells were still in the 
hypoxic environment during this period) followed by con- 
tinued incubation under hypoxia.  Oxygen tension  in the 
medium of hypoxic astrocytes declined to <10 torr within 
5 min after the displacement of hydrogen peroxide. Release 
of IL-6  activity was  dependent on  the concentration of 
hydrogen peroxide  (Fig.  8  A),  and  occurred  in  a  time- 
dependent manner, first evident by 2 h and increasing up to 
Figure  7.  Effect of arginine-free medium, L-NMMA, DPI, NAC, and 
allopurinol on induction of IL-6 activity by astrocytes exposed to H/K. 
(A) Astrocytes ('x,10  s cells/well) were exposed to hypoxia (32 h) followed 
by 16 h of reoxygenation. Culture medium was then replaced with either 
arginine~free medium (AF) 2 h before and during reoxygenation, or, in 
other experiments, I.,NMMA (LNA), DPI, NAC, or allopurinol (AL), 
at the indicated concentrations, was added to the culture 10 rain before 
and during reoxygenation. ID6 activity elaborated into the medium was 
assessed after 16 h by use of the MH-60 cell proliferation assay. * *p <0.01 
by Neuman-Keuhl's analysis. (B) Astrocytes (10  s cells/well) were exposed 
to hypoxia for 32 h. DPI (50 #M) was then added 10 rain before (-I0) 
reoxygenation and at the indicated time points after reoxygenation (the 
start of reoxygenation is designated as time 0). Data shown indicate the 
mean  _+  SD,  and n  =  8. 
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Figure 8.  Induction of astrocyte IL-6  by hydrogen peroxide.  (,4) As- 
trocytes  in  24-well  plates  ("-,10  s  cells/well)  were  incubated  under hypoxic 
(open  Mrs)  or  normoxic (solid  bars)  conditions  for  24  h.  Hydrogen peroxide 
at  the  indicated  concentration  (0--12  raM) was added for  I  rain,  and then 
cultures  were washed three  times and incubated for an additional  12 h 
in  the  same environment as  used previously  (hypoxia  or  normoxia). Con- 
ditioned  medium was harvested  after  12 h for  determination of  IL-6  ac- 
tivity.  (B)  Astrocytes  were  exposed to  hypoxia as  above  for  24  h,  hydrogen 
peroxide (12  raM) was added for  I min, followed  by extensive  washing, 
and the  incubation  was continued for  the  indicated  times  under hypoxia. 
Astrocyte-conditioned medium  was harvested  and Ib6 activity  assessed. 
In  each  case,  "0" denotes  the  activity  of  IL-6  present  in  the  culture  super- 
natant  before  exposure to  hydrogen peroxide.  The means  _+ SD (n =  8) 
are shown. 
2303  Maeda et al. Figure 9.  Effect  of H/P, on Ib6 production by the 
human astrocyte cell line U373. U373 cells ("~3  x  l0  s 
cells/well) were exposed to hypoxia (4-32 h) followed by 
reoxygenation.  At  the  indicated  times,  conditioned 
medium was harvested, and II.-6 activity was measured 
by use of the MH-60 call proliferation assay. Values are 
expressed as the percentage increase  over basal IL-6  produc- 
tion  by U373 cells in normoxic  condition. Data represent 
the means  +_  SD (n  =  6). 
8 h (Fig. 8 B). Elaboration of IL-6 activity by hypoxic astro- 
cytes exposed to hydrogen peroxide (Fig. 8 A, open bars) was 
much greater than in normoxic cultures subjected to the same 
treatment (Fig. 8 A, solid bars). The time course of IL-6 re- 
lease was somewhat more rapid when exogenous hydrogen 
peroxide was added to hypoxic astrocyte cultures (Fig. 8 B) 
compared with reoxygenation,  probably due to addition of 
such a strong oxidant in a concentrated fashion (compared 
with the more sustained production of lower levels of ROIs 
in reoxygenated astrocytes). 
H/R.mediated Induction of lL-6 Activity in a Human Astro- 
cyte Cell Line.  H/R-mediated enhancement of astrocyte IL-6 
production was also observed in the U373 human astrocyte 
cell line. U373 cells have been shown to generate IL-6 con- 
stitutively  under normoxic conditions (122.3  +_  20.1 pg. 
m1-1. well -1 in 12 h) (37). Exposure of U373 cells to H/R 
resulted in IL-6 release above the normoxic baseline by ~410 
+_ 20.3% after 16 h of  reoxygenation. This increase  was most 
apparent in reoxygenated cultures previously exposed to hyp- 
oxia for 32 h (Fig. 9). Hypoxia alone had no effect on U373 
cell IL-6 production (data not shown). 
Effect of  Astrocyte-conditioned Medium After R  on Survival of 
Differentiated PCI2 Cells.  To assess a potentially neurotrophic 
role of  astrocyte-derived  IL-6, the effect  of  conditioned medium 
of astrocytes to H/R  on the viability of PC12 ceils exposed 
to H/R. was assessed. Differentiated PC12 ceils (Fig. 10, 1) 
were vulnerable to injury by H/R. under serum-poor condi- 
tions; almost all cells became nonviable after 24 h hypoxia 
Figure  10.  Effect  of astrocyte-conditioned medium on the viability of PC12 cells exposed to H/R. PC12 cells in 24-well plates (~5  x  10  4 ceils/well), 
differentiated as described (1), were exposed to hypoxia (24 h) followed by reoxygenation (12 h). At the start of reoxygenation,  culture medium was 
changed to either MEM containing Ib6-free fetal bovine serum (0.1%; 2), purified recombinant II=6 (10 ng/ml; 6), or conditioned medium, concen- 
trated 20-fold, derived from astrocytes exposed to H/R (32 h/16 h; 3). In 4 and 5, concentrated astrocyte-conditioned medium was preincubated with 
either antimurine ID6 IgG (10/~g/ml;  4) or antimurine NGF lgG (10/zg/ml; 5) for 60 min at 37~  before addition to PC12 cultures. Phase contrast 
micrographs under each condition are shown (x400). 
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Figure 11.  Expression  of IL-6 activity  and immunohistochemical  evi- 
dence  of  I1-,6 antigen  in gerbil  brain after  bilateral occlusion  of the carotid 
artery. (A) Tissues  were  homogenized  and assayed  for IL-6 activity.  Pro- 
tein content  of samples  was assessed  by BioRad microprotein  assay. Cere- 
bral cortex  (open bars)  and hippocampus  (shaded  bars) were  separated  from 
adult Mongolian  gerbils subjected  to transient forebrain  ischemia  for 5 
min or sham-operated  controls. Values  shown  represent  means +_ SE (. = 
4). (B--E) Tissues were immunostained  for IL-6 antigen as described  in 
Materials and Methods. B and C show normoxic  (x340) and ischemic 
(x560) gerbil cerebral  cortex,  respectively,  stained  with anti-II..6 IgG. D 
shows the same  section  as in C, now double  stained  to reveal  the astrocyte 
marker  glial  fibrillary  acidic  protein  (x560). E shows  ischemic  gerbil  cortex 
stained with nonimmune  IgG (x340). 
followed by 12 h of reoxygenation (cell viability was <20% 
by trypan blue exclusion; Fig.  10, 2). Murine recombinant 
IL-6 (10 ng/ml) or concentrated astrocyte-conditioned  medium 
added at the time of reoxygenation had a protective effect, 
increasing the viability of PC12 cells subjected to H/R  to 
>80%  (Fig.  10, 3 and 6). The protective effect of astrocyte- 
conditioned medium was diminished by preincubation with 
neutralizing antimurine IL-6 antibody (10 #g/ml;  Fig.  10, 
4), but not by neutralizing antimurine NGF antibody (10 
#g/ml; Fig.  10, 5).  These data indicate that astrocytes may 
exert a neurotrophic effect during H/R through production 
of IL-6. 
Expression of  lL-6 in the Brain After Ischemia/Reperfiaion.  To 
complement our studies in cell culture, expression of IL-6 
activity was studied in brain tissue of gerbils after transient 
bilateral occlusion of the common carotid artery. In the cere- 
bral cortex, where viability of neurons is well maintained 
during such an ischemic challenge (34),  IL-6 activity in ex- 
tracts became higher 1 d after ischemia/reperfusion compared 
with sham-operated controls (Fig.  11 A, open bars). In con- 
trast, in extracts of the hippocampal area, where loss of neurons 
becomes apparent 3-4 d  after ischemia/reperfusion (34),  a 
peak of IL-6 activity was observed only 4 d after the isch- 
emic insult (Fig.  11 A, shaded bars). Consistent with these 
data, immunostaining of ischemic gerbil cerebral cortex with 
anti-IL-6 antibody demonstrated that, compared with nor- 
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moxia, increased expression of IL-6 was observed in ischemic 
astrocytes (Fig.  11, B and C, respectively). The identity of 
the cells expressing immunoreactive IL-6 (Fig.  11  C) was 
confirmed by double staining with antibody to glial fibril- 
lary acidic protein (Fig. 11/3).  Nonimmune IgG did not stain 
ischemic gerbil brain  (Fig.  11 E). 
Discussion 
Astrocytes, the major glial cell in the CNS, have recently 
been recognized as participants in the response of the brain 
to environmental perturbations. While astrocytes retain their 
viability even in the face of extreme conditions, as can occur 
during ischemia/reperfusion, they become activated under 
such conditions, allowing them to assume new roles,  as in 
tissue remodelling in the CNS (8). These considerations sug- 
gest parallels  between astrocyte functions in the CNS and 
mononudear phagocyte properties in peripheral vasculature. 
Consistent with this view, astrocytes have been shown to pro- 
duce cytokines, including IL-1, IL-6, interferons, and TGF-B, 
allowing them to orchestrate a cytokine network in the brain, 
as reviewed by Benveniste (13). Another important property 
of astrocytes is their "neuroprotective" function, as exemplified 
by regulation of the ionic milieu, removal of excitatory neu- 
rotransmitters, and induction/maintenance of the blood-brain 
barrier (1, 2, 38). In addition to these "housekeeping" func- tions, astrocytes directly influence the differentiation and sur- 
vival of neurons by producing extrinsic growth/neurotrophic 
factors, such as NGF, basic fibroblast growth factor, and ciliary 
neurotropic  factor (39-41). 
Our  previous  studies  demonstrated  that  mononuclear 
phagocytes and endothelial cells elaborate cytokines after ex- 
posure to H/R (10, 42). This led us to assess whether astro- 
cytes might respond similarly by production of a cytokine(s), 
but one with protective,  neurotrophic properties, such as IL-6. 
The data presented here indicate that astrocytes produce IL-6 
when exposed to hypoxia followed by a period of reoxygena- 
tion.  The range of potential  functions of astrocyte-derived 
IL-6 in ischemia is suggested by previous studies in tissue 
cuhure showing that IL-6 stimulates astrocyte proliferation 
and production of NGF (8, 39), has a neuroprotective effect 
on dopaminergic  and cholinergic neurons  (43,  44),  and an 
NGF-like action on PC12 cells (45).  Although  elucidation 
of the role of astrocyte-derived IL-6 in the CNS will require 
further investigation, the enhanced production of IL-6 in the 
brain in response to ischemia,  along with previous studies 
indicating that IL-6 administered into the brain exerts a pro- 
tective effect on cholinergic neurons subjected to injury by 
N-methyl-D-aspartate (NMDA) agonists (46), suggests that 
IL-6 could have  important  beneficial effects. 
Production of IL-6 by astrocytes in response to H/R occurs 
in a highly specific manner.  Hypoxia upregulates transcrip- 
tion of IL-6 without inducing translation  or release  of the 
IL-6 gene product. This is similar to the increase in platelet- 
derived growth factor B-chain mRNA observed in hypoxic 
endothelium, which also occurs without production of mito- 
genic activity or demonstrable protein (30).  During reoxy- 
genation, activation of an NADPH oxidase-like activity results 
in  astrocyte  generation  of superoxide,  which  serves  as  a 
stimulus for further transcription,  as well as translation and 
release of IL-6. Thus, moderated formation of ROIs is a trigger 
for protein biosynthesis and is not accompanied by astrocyte 
cytotoxicity, in keeping with the capacity of lower levels of 
oxygen free radicals to serve as intracellular  second messengers 
in pathways activated by cytokines and other agents (10, 47). 
The validity of this hypothesis is suggested by experiments 
in which hypoxic astrocytes, with  their  increased levels of 
IL-6 mRNA, can be triggered to synthesize/release IL-6 ac- 
tivity after exposure to hydrogen peroxide (while still main- 
tained in hypoxia), whereas normoxic astrocytes, with very 
low  levels  of IL-6  mRNA,  did  not  produce  comparable 
amounts of IL-6 in response to the same stimulus.  The reasons 
for lack of translation  of the IL-6 mRNA during hypoxia 
and the apparent delay of several hours between generation 
of ROIs and detection of IL-6 are not clear.  This could be 
analogous to observations in spermatogenesis, in which un- 
translated mRNA is apparently translated at a later time after 
induction of a specific set of proteins (48).  Our results em- 
phasize the importance of elucidating mechanisms through 
which hypoxia and reoxygenation induce expression of IL-6 
mRNA  and  translation  and release  of active IL-6. 
Taken together, these data suggest that H/R activates as- 
trocytes, resulting  in their expression of IL-6 neurotrophic 
activity,  as  exemplified by enhanced  PC12  viability  (pilot 
studies with primary rat cortical neurons exposed to super- 
natants  from H/R  astrocytes have yielded similar results). 
Generation of ROIs, though associated with neuronal tox- 
icity (49, 50) in CNS ischemia, can, when moderated,  also 
trigger neuroprotective/neurotrophic properties of astrocytes 
through expression of IL-6. Future studies will be required 
to dissect the potential contribution of IL-6 to reparative mech- 
anisms from that of other mediators implicated in ischemia, 
such as basic fibroblast growth factor and ciliary neurotrophic 
factor (51). 
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